Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Tax Provisions (2017)

Armata Pharmaceuticals (ARMP) has disclosed Tax Provisions for 2 consecutive years, with -$1.3 million as the latest value for Q2 2017.

  • Quarterly Tax Provisions changed N/A to -$1.3 million in Q2 2017 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2017, changed N/A year-over-year, with the annual reading at -$328000.0 for FY2018, 74.81% up from the prior year.
  • Tax Provisions hit -$1.3 million in Q2 2017 for Armata Pharmaceuticals, down from -$73000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of -$73000.0 in Q4 2015 to a low of -$1.3 million in Q2 2017.